Dear <<First Name>>

Welcome to the Lab Bulletin Coronavirus (COVID-19) Update.

This new weekly update aims to help keep our readers updated on the latest laboratory products and news for COVID-19 screening and testing.

If you have any products, technologies or news that will be critical in battling COVID-19 then we would like to hear from you. Please send your press releases to

The team at Lab Bulletin send all of our readers, customers and their families our very best wishes in these most difficult times.

Keep Safe!

Here's our latest news for you <<First Name>>

COVID-19 and maternal health: is the virus a threat?

Dr Laura Moro-Martin, freelance medical writer at Kolabtree, the freelance platform for scientists, explores the effects of COVID-19 on maternal health. Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to escalate worldwide, with Europe and the USA now the epicentres of the pandemic. As of May 1, there are over three million declared cases and almost 240,000 deaths globally, with many countries undergoing community transmission....


HALIX Enters Collaboration with the University of Oxford for GMP Manufacturing of a COVID-19 Vaccine

HALIX B.V. has joined a consortium of partners under the guidance of the University of Oxford, to provide GMP manufacturing services supporting the large scale production of a COVID-19 vaccine (ChAdOx1 nCoV-19), being developed by the University’s Jenner Institute. This GMP manufacturing scale-up is taking place alongside early phase clinical trials. The trials are crucial in testing whether the vaccine is proven to be effective....


Glasgow Lighthouse Lab facility begins processing samples for COVID-19

The Lighthouse Laboratory in Glasgow – a major new COVID-19 testing facility based in Scotland – is now operational. The Lighthouse Lab, which officially started testing samples for COVID-19 this week, is part of what will be the biggest network of diagnostic testing facilities in British history, alongside other Lighthouse Lab sites in Milton Keynes and Alderley Park, which were opened in recent days....


FDA Further Expands EUA for Thermo Fisher Scientific's COVID-19 Diagnostic Tests

Thermo Fisher Scientific Inc., has announced that the U.S. Food and Drug Administration (FDA) has further expanded emergency use authorization (EUA) for its multiplex real-time PCR test intended for the qualitative detection of nucleic acid from SARS‑CoV‑2, the virus that causes COVID-19. "Increasing COVID-19 testing is a top priority in re-opening global economies," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific....


Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA)1 for its new Elecsys® Anti-SARS-CoV-2 antibody test. The test is designed to help determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against SARS-CoV-2. Roche has already started shipping the new antibody test to leading laboratories globally and will ramp up production capacity to high double-digit millions per month....


AI-based precision medicine mining of UK Biobank finds 13 human COVID risk genes and identifies 59 drugs with potential to improve survival in severe COVID-19 patients and sepsis

Data scientists from UK-headquartered AI precision medicine company, PrecisionLife, have used the Company’s proprietary AI enabled precision medicine platform to identify 59 repurposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from severe COVID-19. The new study, released on Biorxiv sought to identify genetic risk factors for sepsis especially in the context of COVID-19, and to use these insights to identify existing....


Rothamsted Research answers White House call for coronavirus data help

A group of researchers based at Rothamsted Research have responded to a request from the White House, Microsoft, Mark Zuckerberg and others to find a way to rapidly sift through the mountain of COVID-19 scientific data. Taking time off from their own research, the Rothamsted team repurposed a tool they had originally developed to help crop scientists, to provide medical researchers with quick and intuitive access to all documented linkages between genes, medicines, and the virus....


Recent Articles

LGC continues to innovate SARS-CoV-2 Quality Solutions to now include the S gene
Rapid, High-Throughput COVID-19 Sample Processing Enabled by Hamilton's MagEx STARlet and Zymo Research's Quick-DNA/RNA™ Viral MagBead Kit
FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies
SARS-CoV-2 has not mutated into different types, new research confirms
Matrix LIMS Used by Liverpool GCPLab in UK Wide Tracking of COVID-19 Patient Outcomes
Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program
BIOHIT supplies COVID-19 detection kits in the UK
Landmark partnership announced for development of COVID-19 vaccine
New PCR brochure available from Gilson - Products specifically for analyzing and testing the COVID-19 virus
Avacta and Cytiva collaborating on COVID-19 rapid test

About Lab Bulletin

Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will also find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information.

Lab Bulletin also publishes three free monthly newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated newsletters for Separation Science, Microscopy and Image Analysis and the Lab Bulletin Monthly Newsletter sent out to over 32,400 readers worldwide.

As a subscriber to our Coronavirus (COVID-19) Update, If you would also like to receive a copy of our Separation Science, Microscopy & Image Analysis or the Lab Bulletin monthly newsletter, simply update your
subscription preferences.
Copyright © 2020 Lab Bulletin, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.